Xu, Quanbin
Zhang, Xiaojuan
Sanchez, Gilson J.
Ramirez, Adrian T.
Liu, Xuedong
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR068254)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM113141)
Article History
Received: 16 April 2021
Accepted: 18 November 2021
First Online: 1 March 2022
Conflict of interest
: X.L. is a co-founder of OnKure Therapeutics Inc and Vesicle Therapeutics Inc and owns equity in both companies. Neither company were involved in the experimental design or funding this study.